Serum Ischemia Modified Albumin Levels in Infertile Couples Underwent in Vitro Fertilization
Keywords:In vitro fertilization, Infertility, Ischemia modified albumin
OBJECTIVE: Ischemia-modified albumin (IMA) is a novel biomarker for diagnosis of distinct disease states including infectious diseases, coronary atherosclerotic disease, hypoxic fetal distress and diabetes mellitus. In vitro fertilization (IVF) is a medical process by which an egg is fertilized by sperm outside the body with varible success rates. It is important for the clinician to assess which women will get pregnant after IVF procedure. In this context we aimed to analyse the possible role of IMA in infertile couples underwent IVF.
STUDY DESINGN: The study group comprised 30 patients with IVF failure, 27 patients with a successful IVF cycle and 34 fertile controls. IVF failure is defined as IVF that does not result in a pregnancy. A rapid, spectrophotometric Albumin Cobalt Binding (ACB) test was used to determine serum IMA levels and results were presented by absorbance units (ABSU).
RESULTS: Serum IMA levels were 0.27 (0.07-0.58), 0.35(0.08-0.88), and 0.37(0.06-1.07) ABSU for patients with IVF cycle failure, successful IVF cycle and controls respectively. No statistically significant difference was observed between study participants.
CONCLUSION: Our results showed that ischemia modified albumin did not provide enough sensitivity or specificity to determine IVF success.
How to Cite
Copyright (c) 2015 Fatma Beyazıt, Osman Balcı, Magdi Adam, Hasan İnal, Yeşim Bardakcı, Nafiye Yılmaz
This work is licensed under a Creative Commons Attribution 4.0 International License.
All the articles published in GORM are licensed with "Creative Commons Attribution 4.0 License (CC BY 4.0)". This license entitles all parties to copy, share and redistribute all the articles, data sets, figures and supplementary files published in this journal in data mining, search engines, web sites, blogs and other digital platforms under the condition of providing references.